Significance of blood-related high-risk behaviors and horizontal transmission of hepatitis B Virus in Iran

Archives of Virology

Volumn 156, Issue 4, 2011, Pages 629-635

  Abedi, Farshid ^a   Madani, Hossain ^a   Asadi, A ^b   Nejatizadeh, Azim ^a  

^a HORMOZGAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Blood Transfusion Organisation ^*  (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BLOODBORNE BACTERIUM; CHILD; DISEASE TRANSMISSION; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HIGH RISK BEHAVIOR; HUMAN; IMMUNOLOGY; IRAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; QUESTIONNAIRE; VIROLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD; BLOOD-BORNE PATHOGENS; CHILD; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 79953172858     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0902-y     Document Type: Article

References (40)

1. Rehermann B, Nascimbeni M (2005) Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5: 215-229.
2. McMahon BJ, Alward WL, Hall DB et al (1985) Acute hepatitis B virus infection: relation of age to clinical expression of disease and subsequent development of the carrier state. J Infect Dis 151: 599-603.
3. Custer B, Sullivan SD, Hazlet TK et al (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: 158-168.
4. Lin HH, Kao JH, Chang TC et al (2003) Secular trend of age specific prevalence of hepatitis B surface and e antigenemia in pregnant women in Taiwan. J Med Virol 69: 466-470.
5. Davis LG, Weber DJ, Lemon SM (1989) Horizontal transmission of hepatitis B virus. Lancet 1: 889-893.
6. Francis DP, Favero MS, Maynard JE (1981) Transmission of hepatitis B virus. Semin Liver Dis 1: 27-32.
7. Seeff LB, Beebe GW, Hoofnagle JH et al (1987) A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. N Engl J Med 316: 965-970.
8. Nair S, Perillo RP (2003) Hepatitis B and D. In: Zakim D, Boyer TD (eds) Hepatoloogy, 4th edn. WB Saunders, Philadelphia, pp 959-1016.
9. Massarat S, Malekzadeh R, Rezvan H (2000) Hepatitis B in Iran. Arch Iran Med 3: 192-201.
10. Hassanjani-Roshan MR, Taheri H (2002) Frequency of chronic active hepatitis in asymptomatic HBV carriers in Babol, Iran. Arch Iran Med 5: 97.
11. Sali S, Bashtar R, Alavian SM (2005) Risk factors in chronic hepatitis B infection: a case-control study. Hepat Mon 5: 109-115.
12. Alavian SM (2007) Net working for overcoming on viral hepatitis in Middle East and central Asia: Asian Hepatitis Network. J Hepat Mon 17: 181-182.
13. Centers for Disease Control, Prevention (2008) Recommendations for identification and public health management of persons with chronic hepatitis B infection. MMWR Morbid Mortal Weekly Rep 57: 1-20.
14. Lee WM (1997) Hepatitis B virus infection. N Engl J Med 337: 1733-1745.
15. Amini S et al (1993) Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population-based study. J Trop Med Hyg 96: 277-287.
16. Saboori Ghanad M, Ghasemi G (1997) Frequency distribution of HBsAg in Hamedan province blood donors. J Hamedan Univ Med Sci Health Serv 4: 76-81.
17. Mojtahedzadeh SM et al (1995) Prevalence of HBsAg and VDRL positive cases in Hamedan province blood donors. J Res Med Shaheed Beheshti Univ Med Sci (3, 4): 74.
18. Farhat A, Khademi G, Mazouman SJ (2003) The prevalence of hepatitis B carrier state in Khorasan province of Iran. Saudi Med J 24: 549-551.
19. Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E et al (2009) Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. New Microbiol 32: 193-198.
20. Taylor R, Montaville B, Levy S et al (1989) Hepatitis B infection in Vanuatu: age acquisition for infection and possible routes of transmission. Asia Pac J Public Health 3: 205-212.
21. Luksamijarulkul P, Maneesri P, Kittigul L (1995) Hepatitis B seroprevalence and risk factors among school-age children in a low socioeconomic community, Bangkok. Asia Pac J Public Health 8: 158-161.
22. Khokhar N, Gill ML, Malik GJ (2004) General seroprevalence of hepatitis C and hepatitis B virus infections in population. J Coll Phys Surg Pak 14: 534-536.
23. Gurol E, Saban C, Oral O, Cigdem A, Armagan A (2006) Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 21: 299-305.
24. Ameen R, Sanad N, Al-Shemmari S et al (2005) Prevalence of viral markers among first-time Arab blood donors in Kuwait. Transfusion 45: 1973-1980.
25. Al Awaidy S, Abu-Elyazeed R, Al Hosani H et al (2006) Seroepidemiology of hepatitis B infection in pregnant women in Oman, Qatar and the United Arab Emirates. J Infect 52: 202-206.
26. Kafi-abad SA, Rezvan H, Abolghasemi H (2009) Trends in prevalence of hepatitis B virus infection among Iranian blood donors, 1998-2007. Transfus Med 19: 189-194.
27. Kafi-abad SA, Rezvan H, Abolghasemi H, Talebian A (2009) Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007. Transfusion 49: 2214-2220.
28. Custer B, Sullivan SD, Hazlet TK et al (2004) Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38(suppl 3): S158-S168.
29. Iran's health and disease surveillance report (2001) Tehran, National Medical Research Centre.
30. Busch MP, Kleinman SH, Nemo GJ (2003) Current and emerging infectious risks of blood transfusions. JAMA 289: 959-963.
31. Szmuness W, Harley EJ, Ikram H, Stevens CE (1978) Sociodemographic aspects of the epidemiology of hepatitis B. In: Viral hepatitis. Franklin Institute Press, Philadelphia, pp 279-320.
32. Merat Shahin, Rezvan Houri, Nouraie Mehdi (2009) The prevalence of hepatitis B surface antigen and anti-hepatitis B core antibody in Iran: a population-based study. Arch Iran Med 12: 225-231.
33. Luksamijarulkul P, Khemnak P, Luksamijarulkul S (2001) A case-control study of hepatitis C virus infection among sexually transmitted disease patients. Chula Med J 45: 413-421.
34. Luksamijarulkul P, Plucktaweesak S (1996) Anti-HIV prevalence and the comparison of some known behaviors between male IDUS with and without anti-HIV, seeking for methadone treatment at 2 governmental hospitals. Chula Med J 40: 989-997.
35. Centers for Disease Control, Prevention (2003) Prevention and control of infections with hepatitis viruses in correctional settings. MMWR 52: 1-33.
36. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV (2000) Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 321: 78-82.
37. Wong VC, Ip HM, Reesink HW et al (1984) Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Lancet 1: 921-926.
38. Adibi P, Ghassemian R, Alavian SM et al (2004) Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers. Saudi Med J 25: 1414-1418.
39. Roshan MR, Samie H, Amiri MJ (2007) Efficacy of hepatitis B vaccine in susceptible spouses of chronic hepatitis B virus infected individuals at the time of marriage. Saudi Med J 28: 540-543.
40. Alavian SM (2007) Ministry of health in Iran is serious about controlling hepatitis B. Hep Mon 7: 3-5.